ＪＣＲファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/12/06 | 1,243 | 1,265 | 1,235 | 1,258 | +33 | +2.7% | 328,200 |
| 2023/12/05 | 1,250 | 1,274 | 1,225 | 1,225 | -26 | -2.1% | 310,600 |
| 2023/12/04 | 1,243 | 1,260 | 1,221 | 1,251 | -10 | -0.8% | 381,800 |
| 2023/12/01 | 1,324 | 1,325 | 1,261 | 1,261 | -63 | -4.8% | 453,400 |
| 2023/11/30 | 1,311 | 1,339 | 1,300 | 1,324 | +12 | +0.9% | 467,100 |
| 2023/11/29 | 1,317 | 1,330 | 1,305 | 1,312 | -8 | -0.6% | 241,900 |
| 2023/11/28 | 1,310 | 1,331 | 1,296 | 1,320 | +9 | +0.7% | 300,400 |
| 2023/11/27 | 1,308 | 1,338 | 1,303 | 1,311 | +4 | +0.3% | 269,000 |
| 2023/11/24 | 1,300 | 1,320 | 1,293 | 1,307 | +2 | +0.2% | 265,500 |
| 2023/11/22 | 1,261 | 1,313 | 1,256 | 1,305 | +40 | +3.2% | 382,000 |
| 2023/11/21 | 1,270 | 1,284 | 1,248 | 1,265 | -5 | -0.4% | 313,100 |
| 2023/11/20 | 1,252 | 1,288 | 1,247 | 1,270 | +22 | +1.8% | 357,200 |
| 2023/11/17 | 1,217 | 1,248 | 1,214 | 1,248 | +23 | +1.9% | 222,300 |
| 2023/11/16 | 1,262 | 1,270 | 1,222 | 1,225 | -43 | -3.4% | 388,500 |
| 2023/11/15 | 1,208 | 1,270 | 1,201 | 1,268 | +80 | +6.7% | 558,900 |
| 2023/11/14 | 1,212 | 1,212 | 1,182 | 1,188 | -24 | -2% | 342,000 |
| 2023/11/13 | 1,213 | 1,224 | 1,200 | 1,212 | -10 | -0.8% | 297,500 |
| 2023/11/10 | 1,219 | 1,236 | 1,209 | 1,222 | -21 | -1.7% | 370,300 |
| 2023/11/09 | 1,225 | 1,249 | 1,213 | 1,243 | +4 | +0.3% | 320,700 |
| 2023/11/08 | 1,225 | 1,264 | 1,225 | 1,239 | +15 | +1.2% | 467,500 |
| 2023/11/07 | 1,192 | 1,242 | 1,192 | 1,224 | +25 | +2.1% | 678,500 |
| 2023/11/06 | 1,232 | 1,233 | 1,198 | 1,199 | +8 | +0.7% | 720,200 |
| 2023/11/02 | 1,144 | 1,205 | 1,140 | 1,191 | +61 | +5.4% | 636,100 |
| 2023/11/01 | 1,156 | 1,160 | 1,125 | 1,130 | -14 | -1.2% | 581,800 |
| 2023/10/31 | 1,077 | 1,156 | 1,063 | 1,144 | +80.5 | +7.6% | 1,164,300 |
| 2023/10/30 | 1,092 | 1,106 | 1,056 | 1,063.5 | -82.5 | -7.2% | 1,245,300 |
| 2023/10/27 | 1,093 | 1,149 | 1,074 | 1,146 | +70.5 | +6.6% | 1,173,300 |
| 2023/10/26 | 1,191 | 1,197 | 1,067.5 | 1,075.5 | -55.5 | -4.9% | 2,044,100 |
| 2023/10/25 | 1,147 | 1,152.5 | 1,113.5 | 1,131 | -3.5 | -0.3% | 653,900 |
| 2023/10/24 | 1,135 | 1,146 | 1,089 | 1,134.5 | +8.5 | +0.8% | 774,200 |
| 2023/10/23 | 1,110 | 1,133 | 1,088.5 | 1,126 | +10.5 | +0.9% | 641,700 |
| 2023/10/20 | 1,119.5 | 1,125.5 | 1,093.5 | 1,115.5 | -20.5 | -1.8% | 597,600 |
| 2023/10/19 | 1,141 | 1,160 | 1,130 | 1,136 | -32 | -2.7% | 391,000 |
| 2023/10/18 | 1,191 | 1,193.5 | 1,159 | 1,168 | -27 | -2.3% | 439,000 |
| 2023/10/17 | 1,200 | 1,210 | 1,185 | 1,195 | +11 | +0.9% | 328,700 |
| 2023/10/16 | 1,235 | 1,236 | 1,176 | 1,184 | -49 | -4% | 482,000 |
| 2023/10/13 | 1,254 | 1,264 | 1,225.5 | 1,233 | -39.5 | -3.1% | 470,300 |
| 2023/10/12 | 1,244.5 | 1,277 | 1,237.5 | 1,272.5 | +28.5 | +2.3% | 347,400 |
| 2023/10/11 | 1,260 | 1,266 | 1,235.5 | 1,244 | -19 | -1.5% | 461,900 |
| 2023/10/10 | 1,278 | 1,292.5 | 1,247 | 1,263 | -12.5 | -1% | 633,600 |
| 2023/10/06 | 1,286.5 | 1,302 | 1,252 | 1,275.5 | +11.5 | +0.9% | 781,400 |
| 2023/10/05 | 1,335 | 1,335 | 1,235 | 1,264 | -81.5 | -6.1% | 1,385,400 |
| 2023/10/04 | 1,359 | 1,385 | 1,337 | 1,345.5 | -39 | -2.8% | 966,100 |
| 2023/10/03 | 1,402 | 1,444 | 1,371.5 | 1,384.5 | -37.5 | -2.6% | 1,110,200 |
| 2023/10/02 | 1,495.5 | 1,503.5 | 1,408 | 1,422 | -73.5 | -4.9% | 1,498,200 |
| 2023/09/29 | 1,496 | 1,567 | 1,430 | 1,495.5 | +119.5 | +8.7% | 3,949,600 |
| 2023/09/28 | 1,388.5 | 1,396.5 | 1,341.5 | 1,376 | -5.5 | -0.4% | 369,300 |
| 2023/09/27 | 1,327.5 | 1,381.5 | 1,326.5 | 1,381.5 | +43.5 | +3.3% | 402,500 |
| 2023/09/26 | 1,362.5 | 1,369.5 | 1,334.5 | 1,338 | -43 | -3.1% | 386,500 |
| 2023/09/25 | 1,366 | 1,437.5 | 1,358 | 1,381 | +32 | +2.4% | 657,700 |
101～
150
件表示中 / 6704件
類似銘柄と比較する
現在ご覧いただいている「ＪＣＲファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＪＣＲファーマ | 80,000円 | +32.2% | +84.6% | 2.50% | 13.68倍 | 1.78倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| 鳥居薬 | 397,500円 | +7.3% | +16.8% | 3.02% | 23.78倍 | 0.93倍 |
|
ＪＴ傘下。自社製品の腎・透析、アレルゲン等の開発強化。柱の抗ＨＩＶ薬の販売権喪失が直撃 |
| ゼリア新薬 | 209,900円 | +6.8% | +18.7% | 2.10% | 13.22倍 | 1.22倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 栄研化 | 200,400円 | -6.4% | -45.4% | 2.54% | 22.81倍 | 1.39倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割弱。尿検査（ウロ）、遺伝子検査も育成 |
| あすかＨＤ | 211,700円 | +2.6% | +5.1% | 1.89% | 9.67倍 | 1.02倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム
